Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells)
Clinical trial NCT04813562 · UNKNOWN
Trial details
- NCT number
- NCT04813562
- Sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-23
- Primary completion
- 2022-07-30
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.